Acute HIV infection: impact on the spread of HIV and transmission of drug resistance

ObjectiveTo assess the impact of primary HIV infection (PHI) on the spread of HIV and the temporal trends in transmission of HIV drug resistance between 1996 and 1999 in Switzerland. MethodsSequencing of the genes for reverse transcriptase (RT) and protease was performed for 197 individuals with documented PHI. Phylogenetic analyses were confronted with epidemiological data. ResultsSignificant clustering was demonstrated for 29% of the RT sequences. All these cases occurred closely together in place and time; contact tracing demonstrated transmission at the time of PHI in 30% of them. Genotypic drug resistance was detected in 8.6% of PHI individuals in 1996, 14.6% in 1997, 8.8% in 1998 and 5.0% in 1999. Drug-resistant variants were identified in 11.3% of individuals infected by homosexual contacts, 6.1% by heterosexual contacts, 13% of intravenous drug users and more frequently in men (10.4%) than women (2.6%). Potential factors involved in the recent decrease of transmission of drug-resistant variants include increase of HIV non-B subtypes from 23% in 1996 to 35% in 1999 (only one non-B subtype had resistance mutations) and a steady increase of patients with undetectable viraemia as documented in Swiss HIV Cohort Study (10% in 1996 vs 53% in 1999). ConclusionsPhylogenetic and epidemiological analyses underline the impact of PHI in the spread of HIV. Moreover, this study indicates that drug resistance transmission may have decreased recently in Switzerland through the increased frequency of infection with HIV non-B subtypes and the steady increase of patients with undetectable viraemia.

[1]  P. Sonnenberg,et al.  Tuberculosis control and molecular epidemiology in a South African gold-mining community , 2000, The Lancet.

[2]  A. Telenti,et al.  Virological and immunological characteristics of HIV treatment failure , 2000, AIDS.

[3]  P. Massip,et al.  Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV‐1 infection , 2000, Journal of medical virology.

[4]  J. Mascola,et al.  Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnel , 2000, AIDS.

[5]  S. Hammer,et al.  Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. , 2000, JAMA.

[6]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[7]  F. Brun-Vézinet,et al.  HIV-1 diversity in France, 1996–1998 , 2000 .

[8]  M A Wainberg,et al.  Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use , 2000, AIDS.

[9]  D. Richman,et al.  Drug Resistance Patterns, Genetic Subtypes, Clinical Features, and Risk Factors in Military Personnel with HIV-1 Seroconversion , 1999, Annals of Internal Medicine.

[10]  E. Rosenberg,et al.  Reduced antiretroviral drug susceptibility among patients with primary HIV infection. , 1999, JAMA.

[11]  Y. Cao,et al.  HIV-1 drug resistance in newly infected individuals. , 1999, JAMA.

[12]  J. Hansen,et al.  Nosocomial HIV-transmission in an outpatient clinic detected by epidemiological and phylogenetic analyses. , 1999, AIDS.

[13]  S. Yerly,et al.  Transmission of antiretroviral-drug-resistant HIV-1 variants , 1999, The Lancet.

[14]  K. Lole,et al.  Full-Length Human Immunodeficiency Virus Type 1 Genomes from Subtype C-Infected Seroconverters in India, with Evidence of Intersubtype Recombination , 1999, Journal of Virology.

[15]  S. Yerly,et al.  Use of highly sensitive assays for the evaluation of post-exposure HIV prophylaxis. , 1998, AIDS.

[16]  M. Safar,et al.  Genetically Related Human Immunodeficiency Virus Type 1 in Three Adults of a Family with No Identified Risk Factor for Intrafamilial Transmission , 1998, Journal of Virology.

[17]  J. Pillonel,et al.  Increasing diversity of HIV‐1M serotypes in French blood donors over a 10‐year period (1985–1995) , 1997, AIDS.

[18]  S M Pollock,et al.  The role of early HIV infection in the spread of HIV through populations. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[19]  I. Longini,et al.  Role of the primary infection in epidemics of HIV infection in gay cohorts. , 1995, Journal of acquired immune deficiency syndromes.

[20]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[21]  R. Gelber,et al.  Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. , 1994, The New England journal of medicine.

[22]  J. Saurat,et al.  Symptomatic primary infection due to human immunodeficiency virus type 1: review of 31 cases. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  D. Cooper,et al.  Identification of HIV‐1 in semen following primary HIV‐1 infection , 1992, AIDS.

[24]  S. J. Clark,et al.  High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. , 1991, The New England journal of medicine.

[25]  D. Ho,et al.  Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. , 1991, The New England journal of medicine.

[26]  P. Piot,et al.  A cluster of HIV infection among heterosexual people without apparent risk factors. , 1989, The New England journal of medicine.

[27]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[28]  W. Fitch,et al.  Construction of phylogenetic trees. , 1967, Science.

[29]  H. Fleury,et al.  HIV-1 diversity in France, 1996-1998. The AC 11 laboratory network. , 2000, AIDS.

[30]  [Therapeutic management of HIV-infected subjects. Report of the expert group under the direction of Prof. J.F. Delfraissy, 1999]. , 2000, Presse medicale.

[31]  J. Delfraissy,et al.  Prise en charge thérapeutique des personnes infectées par le VIH , 2000 .

[32]  M. Zwahlen,et al.  High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. , 1999, Journal of acquired immune deficiency syndromes.

[33]  M. Newell,et al.  Maternal viral load and vertical transmission of HIV-1: an important factor but not the only one. The European Collaborative Study. , 1999, AIDS.